Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis
Authors:
- 26 June 2024
- journal article
- review article
- Published by VM Media Group sp. z o.o in Endokrynologia Polska
- Vol. 75 (3) , 237-252
Abstract
Metabolic-associated fatty liver disease (MAFLD) is a newly coined term that links the presence of liver steatosis (characterised by the accumulation of lipids in at least 5% of liver cells) with a condition of overall systemic metabolic dysfunction. MAFLD impacts 24–36% of the global population. As per the official guidelines, a diagnosis of MAFLD can be made when hepatosteatosis is accompanied by type 2 diabetes mellitus, overweight, obesity, or at least 2 other specific metabolic abnormalities (increased waist circumference, hypertension, dyslipidaemia, prediabetes, elevated C-reactive protein level, or increased homeostasis model assessment of insulin resistance: HOMA-IR). MAFLD is a heterogeneous illness associated with multiple diseases that impact various organs, particularly endocrine organs. Endocrinopathies can significantly influence the progression and severity of MAFLD. This paper provides a brief overview of the existing research on the connection between liver steatosis and the functioning of endocrine organs. The authors also propose dividing endocrine diseases into those having a possible, strong, and clear relationship with hepatosteatosis (for the purpose of preliminary recommendations regarding the need for monitoring the possible progression of MAFLD in these groups of patients). Keywords: metabolic-associated fatty liver disease liver obesity diabetes MAFLD NAFLDKeywords
This publication has 177 references indexed in Scilit:
- Independent effects of physical activity in patients with nonalcoholic fatty liver disease #Hepatology, 2009
- The association of nonalcoholic steatohepatitis and tamoxifen in patients with breast cancerCancer, 2009
- Increased hepatic steatosis and insulin resistance in mice lacking hepatic androgen receptorHepatology, 2008
- Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver diseaseHepatology, 2008
- The NAFLD fibrosis scoreHepatology, 2007
- Long‐term follow‐up of patients with NAFLD and elevated liver enzymes†‡Hepatology, 2006
- Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfectionHepatology, 2006
- Therapeutic efficacy of an angiotensin II receptor antagonist in patients with nonalcoholic steatohepatitisHepatology, 2004
- Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunctionHepatology, 2004
- Transcriptional activation of the human insulin receptor gene by 1,25‐dihydroxyvitamin D3Cell Biochemistry and Function, 2002